We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomedical Engineers Reveal Organ-on-Chip Device for Drug Testing and Organ Repair

By LabMedica International staff writers
Posted on 21 Mar 2016
A soft, biodegradable polymer was used to form a three-dimensional organ-on-chip device for growth of artificial organs that could be used for drug testing or the repair or replacement of damaged organs.

Poly(octamethylene maleate (anhydride) citrate) (POMaC) is a soft, biodegradable elastomer with the potential to be a good biomaterial for use in scaffolds for soft tissue engineering. More...
POMaC is notable for its dual cross-linking mechanism that allows the engineer to manipulate the resultant mechanical properties of the material during preparation.

Investigators at the University of Toronto (Canada) used POMaC to fashion "AngioChip" scaffolds comprising a series of thin layers about 50 to 100 micrometers wide, stamped with a pattern of nanopore and micro-hole channels. The layers, which resembled computer microchips, were then stacked into a three-dimensional structure of synthetic blood vessels. The scaffold was bathed in media containing living cells. The cells rapidly attached to the inside and outside of the channels and began growing.

The investigators reported in the March 7, 2016, online edition of the journal Nature Materials that incorporation of nanopores and micro-holes in the vessel walls enhanced permeability, and permitted intercellular crosstalk and extravasation of monocytes and endothelial cells on biomolecular stimulation. They also showed that vascularized hepatic tissues and cardiac tissues engineered by using AngioChips processed clinically relevant drugs delivered through the vasculature, and that millimeter-thick cardiac tissues could be engineered in a scalable manner. Furthermore, AngioChip cardiac tissues implanted into the femoral vessels of rat hindlimbs established immediate blood perfusion.

"It is a fully three-dimensional structure complete with internal blood vessels," said senior author Dr. Milica Radisic, professor of biomedical engineering at the University of Toronto. "It behaves just like vasculature, and around it there is a lattice for other cells to attach and grow. Previously, people could only do this using devices that squish the cells between sheets of silicone and glass. You needed several pumps and vacuum lines to run just one chip. Our system runs in a normal cell culture dish, and there are no pumps; we use pressure heads to perfuse media through the vasculature. The wells are open, so you can easily access the tissue. Our liver actually produced urea and metabolized drugs."

Related Links:

University of Toronto



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.